Get the Stockscreener App
46.83
1.46%
-0.703
Collegium Pharmaceutical Inc stock is traded at $46.83, with a volume of 56,696.
It is down -1.46% in the last 24 hours and up +30.66% over the past month.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
See More
Previous Close:
$47.53
Open:
$47.59
24h Volume:
56,696
Relative Volume:
0.13
Market Cap:
$1.48B
Revenue:
$566.77M
Net Income/Loss:
$48.16M
P/E Ratio:
39.35
EPS:
1.19
Net Cash Flow:
$274.29M
1W Performance:
+0.34%
1M Performance:
+30.66%
6M Performance:
+58.78%
1Y Performance:
+56.81%
1-Day Range:
$46.81
$47.60
1-Week Range:
$45.82
$48.37
52-Week Range:
$23.23
$48.37
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Name
Collegium Pharmaceutical Inc
Sector
Phone
781-713-3699
Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
46.84 | 1.50B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
119.21 | 53.06B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.22 | 45.11B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.505 | 42.44B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.18 | 32.59B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.58 | 20.84B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Needham | Hold → Buy |
| Jul-30-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-07-24 | Upgrade | Jefferies | Hold → Buy |
| May-10-24 | Downgrade | Needham | Buy → Hold |
| May-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-04-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-25-23 | Reiterated | Needham | Buy |
| May-02-23 | Resumed | Jefferies | Buy |
| Aug-08-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-15-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Aug-06-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Jul-14-20 | Initiated | BWS Financial | Sell |
| May-27-20 | Initiated | Guggenheim | Neutral |
| Feb-19-20 | Resumed | Jefferies | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| May-03-19 | Resumed | H.C. Wainwright | Buy |
| Apr-12-19 | Resumed | Janney | Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Jan-16-19 | Reiterated | Needham | Buy |
| Mar-08-18 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-18 | Reiterated | Needham | Buy |
| Dec-05-17 | Reiterated | Needham | Buy |
| Sep-11-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Reiterated | Needham | Buy |
| Sep-13-16 | Initiated | Gabelli & Co | Buy |
| Jun-01-15 | Initiated | Jefferies | Buy |
| Jun-01-15 | Initiated | Needham | Buy |
| Jun-01-15 | Initiated | Piper Jaffray | Overweight |
View All
Collegium Pharmaceutical Inc Stock (COLL) Latest News
Can Collegium Pharmaceutical Inc. stock withstand economic slowdown2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
Can Collegium Pharmaceutical Inc. (354) stock hit consensus price targetsJuly 2025 News Drivers & Consistent Growth Stock Picks - Newser
What RSI levels show for Collegium Pharmaceutical Inc. (354) stockEarnings Trend Report & Weekly High Return Forecasts - Newser
How Collegium Pharmaceutical Inc. stock responds to policy changesWeekly Trade Recap & Real-Time Stock Movement Alerts - Newser
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 12-Month HighStill a Buy? - MarketBeat
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - Yahoo Finance
Collegium Pharmaceutical, Inc. (COLL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Will Collegium Pharmaceutical Inc. (354) stock justify high valuationQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Will Collegium Pharmaceutical Inc. (354) stock benefit from commodity supercycle2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser
Will Collegium Pharmaceutical Inc. (354) stock sustain uptrend momentum2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Collegium Pharmaceutical stock hits all-time high at 48.19 USD By Investing.com - Investing.com India
Loomis Sayles & Co. L P Increases Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Will Collegium Pharmaceutical Inc. (354) stock hit analyst forecastsWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Can Collegium Pharmaceutical Inc. (354) stock withstand sector downturnsPortfolio Risk Report & AI Driven Price Forecasts - Newser
Why Collegium Pharmaceutical Inc. (354) stock is a strong analyst pickTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Ballast Asset Management LP Makes New Investment in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo Finance
Collegium Pharmaceutical Reports Record Q3 2025 Results - MSN
Collegium Pharmaceutical (COLL): Exploring Valuation After Recent Share Price Surge - simplywall.st
Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - news.stocktradersdaily.com
Is Collegium Pharmaceutical Inc 354 a good long term investmentEarnings Per Share Trends & Low Risk Portfolio Growth - earlytimes.in
Why Investors Shouldn't Be Surprised By Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 26% Share Price Surge - 富途牛牛
Free cash flow per share of Collegium Pharmaceutical, Inc. – TRADEGATE:354 - TradingView
Collegium Pharmaceutical collaborates with Paris Hilton - MSN
Why 2025 is a Dynamic and Transformative Year for Collegium - MSN
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Has Analyst Spotlight on COLL Revealed a Turning Point in Its Competitive Advantage? - simplywall.st
Why Collegium Pharmaceutical Inc. stock is popular among millennialsPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Collegium Pharmaceutical Inc. (354) stock a safe buy pre earningsQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com
Is Collegium Pharmaceutical Inc. (354) stock in buy zone after pullback2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com
Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? - Yahoo Finance
A Fresh Look at Collegium Pharmaceutical (COLL) Valuation After Upbeat 2025 Guidance and Strong Q3 Earnings - simplywall.st
How Collegium Pharmaceutical Inc. stock performs during Fed tightening cyclesSwing Trade & Daily Price Action Insights - newser.com
What valuation ratios show for Collegium Pharmaceutical Inc. (354) stockPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Measuring Collegium Pharmaceutical Inc.’s beta against major indicesPortfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
How Collegium Pharmaceutical Inc. (354) stock reacts to stronger dollarTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Collegium Pharma and Entegris have been highlighted as Zacks Bull and Bear of the Day - sharewise.com
Collegium Pharmaceutical Inc Stock (COLL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Collegium Pharmaceutical Inc Stock (COLL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Fallon John A. | Director |
Nov 12 '25 |
Sale |
47.21 |
34,853 |
1,645,536 |
64,634 |
1.61%
2.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):